Abstract
The association of the Interleukin-23 receptor (IL-23R) gene with Ankylosing Spondylitis (AS), which is well-documented in Caucasian populations, is notably absent in Korean patients. This study investigates the genetic susceptibility of the IL-23R locus in a native Korean cohort, finding no significant association between selected polymorphisms and the disease.
Introduction
Ankylosing Spondylitis (AS) is a chronic, systemic inflammatory disease that primarily targets the axial skeleton and sacroiliac joints. While the HLA-B27 allele remains the most significant genetic risk factor, it does not fully explain the disease's heritability. Large-scale genome-wide association studies (GWAS) in Caucasian populations have identified the IL-23R gene as a major non-HLA susceptibility locus.
However, genetic architecture often varies across ethnic groups. A variant that confers risk in one population might be rare or non-existent in another. This study addresses a critical gap in the literature: Does the IL-23R association hold true for native Koreans, or are there different genetic drivers at play in Asian populations?
Methods
Study Population
The researchers conducted a case-control association study involving 843 native Korean individuals. The cohort consisted of 451 patients with AS (diagnosed via the modified New York criteria) and 392 ethnically matched healthy controls. The patient group included 419 men and 32 women, with a mean age of approximately 35.8 years.
SNP Selection and Genotyping
Ten specific Single Nucleotide Polymorphisms (SNPs) within the IL-23R gene cluster were targeted. These SNPs were selected based on prior strong associations with AS or Inflammatory Bowel Disease (IBD) in Caucasian studies. DNA was extracted from peripheral blood and genotyped using the Sequenom MassArray platform, a high-throughput system utilizing mass spectrometry.
Statistical Analysis
Standard quality controls were performed, including checks for Hardy-Weinberg equilibrium. The team used chi-squared tests, the Cochrane-Armitage test for trend, and haplotype-based association analysis to identify potential links between genetic patterns and the presence of the disease.
Results
The analysis revealed no statistically significant association between any of the 10 IL-23R SNPs and AS in the Korean cohort. As shown in Table 1, the odds ratios (OR) for the polymorphic SNPs hovered near 1.0, indicating no increased risk or protection.
Notably, two SNPs (rs11456804 and rs11209026) that are highly relevant in Western cohorts were found to be non-polymorphic in this Korean population, as indicated by the absence of frequency data in the table. Furthermore, haplotype analysis and subgroup analyses for clinical features such as uveitis and peripheral arthritis failed to identify any significant genetic links.
Discussion
The most striking insight from this study is the lack of "portability" of genetic risk factors between ethnic groups. Despite AS presenting with similar clinical hallmarks—such as sacroiliitis and a high prevalence of HLA-B27—in both Caucasians and Koreans, the secondary genetic pathways appear to differ significantly.
These findings serve as a cautionary tale for personalized medicine. Risk scores developed using data from one ancestral group may be entirely inaccurate when applied to another. The study underscores the critical importance of diversity in genomics research.
Limitations and Future Directions
While the sample size of 843 subjects is respectable for a candidate gene study, it may lack the statistical power to detect very subtle genetic effects compared to massive international meta-analyses. Additionally, the study focused narrowly on IL-23R; other components of the IL-23/IL-17 signaling pathway might harbor relevant risk variants for Koreans.
Future research should involve larger-scale GWAS specifically targeting Asian populations to discover unique susceptibility loci. This would facilitate a more globally inclusive understanding of the genetic basis of AS and support the development of population-specific diagnostic and therapeutic tools.
Summary updated